Objective
This small,
feasibility
study was conducted to assess technical aspects, handling and performance of
the dual layer micromesh RoadsaverTM carotid artery stent in the treatment of extracranial carotid artery disease
and tandem lesions in ischemic stroke patients.
Study Group
- Single-center,
Single-arm,
Case
series
- 7
patients
(mean
age: 75.0 ±
11.4
years, 5 males)
- 5
symptomatic
(elective)
cases
- 2 acute
stroke (tandem
lesions) cases
Methods
All
patients:
- 5000
IU
Heparin: 7/7
- Predilatation:
0/7
- Embolic
protection
device
(EPD) use:
0/7
- Post-dilatation:
6/7
- Elective
patients:
- DAPT
for 3 days pre-procedure (aspirin & clopidogrel)
- Acute
patients:
- CAS
prior to Intracranial Thrombectomy
- DAPT
(intravenous aspirin (500 mg) & clopidogrel (300 mg) oral through the
stomach tube)
- No
bridging therapy with recombinant tissue plasminogen activator
Results
- In all patients good
navigability in
- supra-aortic vessels
- aortic arch types 1 - 3
- in straight or elongated ICAs
- Elective
patients (N=5):
- No peri-/post-procedural complications:
5/5
- Clinical symptoms improvement: 5/5 (mRS)
- ECA
patent at 6 months: 5/5 (DUS)
- Acute
patients (N=2):
- Time
to recanalization pt1: 41 and pt2: 56 min
- TICI
2b or greater flow in both patients.
- No
haemorrhagic transformation or parenchymal hematoma
Conclusion
